v3.26.1
Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues [Abstract]            
Revenues $ 264,162   $ 251,402   $ 516,699 $ 496,403
Depreciation and amortization (10,083)   (9,279)   (20,005) (18,330)
Income tax provision (3,020)   (4,809)   (4,384) (8,188)
Interest expense (16,222)   (30,097)   (32,553) (59,946)
Loss on extinguishment and modification of debt (1,053)   0   (1,053) 0
Gain (Loss) on disposal of property and equipment         (113) 146
Stock-based compensation         (25,011) (14,720)
Net income 2,745 $ 1,717 (7,226) $ (7,687) 4,462 (14,913)
Patient Service Revenue            
Revenues [Abstract]            
Revenues 194,902   189,347   383,894 373,564
Operating Segments            
Revenues [Abstract]            
Revenues 264,162   251,402   516,699 496,403
Other segment items [1] 207,717   195,128   409,055 389,129
Adjusted EBITDA 56,445   56,274   107,644 107,274
Depreciation and amortization (10,083)   (9,279)   (20,005) (18,330)
Income tax provision (3,020)   (4,809)   (4,384) (8,188)
Amortization of basis difference (573)   (500)   (1,105) (1,000)
Interest expense (16,222)   (30,097)   (32,553) (59,946)
Loss on extinguishment and modification of debt (1,053)       (1,053)  
Gain (Loss) on disposal of property and equipment 24   (16)   (113) 146
Stock-based compensation (12,737)   (8,346)   (25,011) (14,720)
Severance and executive recruiting [2] (686)   (803)   (1,631) (2,173)
Strategic initiatives and implementation [3] (2,659)   (1,018)   (3,484) (1,886)
Transaction costs [4] (707)   (3,875)   (3,289) (7,464)
Litigation and settlements [5] (1,173)   0   (1,202) 128
Other [6] (87)   (142)   (82) (158)
Adjustments for equity in earnings of unconsolidated affiliates [7] (4,724)   (4,615)   (9,270) (8,596)
Net income 2,745   (7,226)   4,462 (14,913)
Operating Segments | Patient Service Revenue            
Revenues [Abstract]            
Revenues 203,735   198,185   401,053 390,483
Operating Segments | Management Fee and Other Revenue [Member]            
Revenues [Abstract]            
Revenues 60,427   53,217   115,646 105,920
Operating Segments | Outpatient            
Revenues [Abstract]            
Revenues 196,209   187,198   384,108 367,999
Other segment items [1] 149,844   140,216   299,370 279,196
Adjusted EBITDA 46,365   46,982   84,738 88,803
Operating Segments | Outpatient | Patient Service Revenue            
Revenues [Abstract]            
Revenues 143,747   138,909   281,839 272,339
Operating Segments | Outpatient | Management Fee and Other Revenue [Member]            
Revenues [Abstract]            
Revenues 52,462   48,289   102,269 95,660
Operating Segments | Professional            
Revenues [Abstract]            
Revenues 72,245   66,328   140,403 132,214
Other segment items [1] 62,165   57,036   117,497 113,743
Adjusted EBITDA 10,080   9,292   22,906 18,471
Operating Segments | Professional | Patient Service Revenue            
Revenues [Abstract]            
Revenues 64,280   61,400   127,026 121,954
Operating Segments | Professional | Management Fee and Other Revenue [Member]            
Revenues [Abstract]            
Revenues 7,965   4,928   13,377 10,260
Operating Segments | Intersegment Eliminations            
Revenues [Abstract]            
Revenues (4,292)   (2,124)   (7,812) (3,810)
Other segment items [1] (4,292)   (2,124)   (7,812) (3,810)
Adjusted EBITDA 0   0   0 0
Operating Segments | Intersegment Eliminations | Patient Service Revenue            
Revenues [Abstract]            
Revenues $ (4,292)   $ (2,124)   $ (7,812) $ (3,810)
[1] Other segment items for both segments include certain operating expenses that are not regularly provided to the CODM on a segment basis and that are identifiable with that segment, including general and administrative expenses.
[2] Includes severance and recruiting expenses for executive leadership departures as part of strategic organizational changes.
[3] Includes third-party consulting, implementation and integration expenses incurred as part of the Company’s strategic transformation and optimization initiatives, specifically related to the deployment of a new technology system and labor model, as well as the development, customization and integration of a new enterprise resource planning system.
[4] Includes costs for third-party non-recurring IPO costs, buy-side and sell-side due diligence activities to evaluate and execute potential mergers and acquisitions, integrate acquired businesses and one-time employee retention bonuses related to potential mergers and acquisitions.
[5] Consists of litigation and settlement costs for matters not related to core operations.
[6] Consists of other costs related to debt financing, certain de novo start-up costs related to outpatient imaging centers and certain exit costs related to closed outpatient imaging centers.
[7] Adjusts for the Company’s proportional share of depreciation and amortization, interest expense and losses/gains on asset disposals related to unconsolidated affiliates, which are included in equity in earnings from unconsolidated affiliates on the accompanying condensed consolidated statements of operations and comprehensive income (loss).